ANALYSIS OF UNFAVORABLE PROGNOSTIC FACTORS IN PATIENTS WHO RECEIVED HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL HEMOPOIETIC STEM CELLS TRANSPLANTATION FOR RELAPSES AND RESISTANT FORMS OF HODGKIN’’S LYMPHOMA. (2018). Voprosy Onkologii, 64(3), 414-418. https://doi.org/10.37469/0507-3758-2018-64-3-414-418